Imad Sheiban

Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) score

• Biondi-Zoccai G,
• Romagnoli E,
• Castagno D,
• Sheiban I,
• De Servi S,
• Tamburino C,
• Colombo A,
• Burzotta F,
• Presbitero P,
• Bolognese L,
• Paloscia L,
• Rubino P,
• Sardella G,
• Briguori C,
• Niccoli L,
• Franco G,
• Di Girolamo D,
• Piatti L,
• Greco C,
• Petronio A,
• Loi B,
• Benassi A,
• Patti A,
• Gaspardone A,
• Frati G,
• Sangiorgi G

EuroIntervention 2012;8:359-367 published online ahead of print May 2012

Published in Volume 8 Number 3, July 2012

In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry

• Galassi A,
• Tomasello S,
• Reifart N,
• Werner G,
• Sianos G,
• Bonnier H,
• Sievert H,
• Ehladad S,
• Bufe A,
• Schofer J,
• Gershlick A,
• Hildick-Smith D,
• Escaned J,
• Erglis A,
• Sheiban I,
• Thuesen L,
• Serra A,
• Christiansen E,
• Buettner A,
• Costanzo L,
• Barrano G,
• Di Mario C

EuroIntervention 2011;7:472-479

Published in Volume 7 Number 4, August 2011

Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence

• Butera G,
• Biondi-Zoccai G,
• Sangiorgi G,
• Abella R,
• Giamberti A,
• Bussadori C,
• Sheiban I,
• Saliba Z,
• Santoro T,
• Pelissero G,
• Carminati M,
• Frigiola A

EuroIntervention 2011;7:377-385

Published in Volume 7 Number 3, July 2011

TAVI improves quality of life in high surgical risk patients with severe symptomatic aortic stenosis

• Salizzoni S,
• Giordana F,
• La Torre M,
• Revelli L,
• Grosso Marra W,
• D’Amico M,
• Sheiban I,
• Marra S,
• Gaita F,
• Rinaldi M

Published in Volume 7 Supplement M, May 2011

Early and long-term outlook of PCI for bifurcation lesions in young patients

• Sangiorgi G,
• Sheiban I,
• De Servi S,
• Tamburino C,
• Capodanno D,
• Biondi-Zoccai G,
• Romagnoli E

Published in Volume 7 Supplement M, May 2011

Small coronary vessels stenting in the DES era: very long-term (>3 years) clinical outcomes

• Quadri G,
• D’ascenzo F,
• Longo G,
• Bollati M,
• Gonella A,
• Di Cuia M,
• Omedè P,
• Moretti C,
• Sciuto F,
• Biondi-Zoccai G,
• Gaita F,
• Sheiban I

Published in Volume 7 Supplement M, May 2011

Improving clinical risk prediction for PCI for bifurcation lesions: the ACEF (age, creatinine, ejection fraction) score

• Sangiorgi G,
• Sheiban I,
• De Servi S,
• Tamburino C,
• Capodanno D,
• Biondi-Zoccai G,
• Romagnoli E

Published in Volume 7 Supplement M, May 2011

PCI outcomes in nonagenarians: data from a systematic review

• Presutti D,
• Sillano D,
• Moretti C,
• Resmini C,
• Di Cuia M,
• Omedè P,
• Sciuto F,
• Biondi-Zoccai G,
• Gaita F,
• Sheiban I

Published in Volume 7 Supplement M, May 2011

Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 225,536 patients and 4,203 thromboses

• D’ascenzo F,
• Biondi-Zoccai G,
• Clementi F,
• Sheiban I,
• Gaita F,
• Modena M,
• Sangiorgi G

Published in Volume 7 Supplement M, May 2011

When are two stents needed? Which technique is the best? How to perform?

• Latib A,
• Moussa I,
• Sheiban I,
• Colombo A

EuroIntervention Supplement (2010) Vol. 6 (Supplement J) J81-J87

Published in Volume 6 Supplement J, December 2010

Diabetes mellitus in patients undergoing percutaneous drug-eluting stent implantation: short and long term results

• Longo G,
• D’ascenzo F,
• Gonella A,
• Pullara A,
• Biondi-Zoccai G,
• Moretti C,
• Sciuto F,
• Omedè P,
• Trevi GP,
• Sheiban I

Published in Volume 6 Supplement H, May 2010

Culprit-only versus multivessel percutaneous coronary intervention for multivessel disease in patients with ST-elevation myocardial infarction: evidence from a 30,886-patient meta-analysis

• Biondi-Zoccai G,
• Lotrionte M,
• Moretti C,
• Sciuto F,
• Omedè P,
• Abbate A,
• Agostoni P,
• Sangiorgi G,
• Sheiban I

Published in Volume 6 Supplement H, May 2010

Intravascular ultrasound does not provide any significant clinical benefit for percutaneous coronary intervention of bifurcation lesions

• Biondi-Zoccai G,
• Sheiban I,
• Romagnoli E,
• De Servi S,
• Tamburino C,
• Colombo A,
• Sardella G,
• Lioy E,
• Capodanno D,
• Sangiorgi G

Published in Volume 6 Supplement H, May 2010

Comparing ticagrelor versus prasugrel for the treatment of patients with acute coronary syndromes: evidence from a 32,983-patient adjusted indirect comparison meta-analysis

• Biondi-Zoccai G,
• Lotrionte M,
• Moretti C,
• Sciuto F,
• Omedè P,
• Abbate A,
• Agostoni P,
• Romagnoli E,
• Sangiorgi G,
• Sheiban I

Published in Volume 6 Supplement H, May 2010

Sex-related differences in patients undergoing percutaneous unprotected left main stenting

• Sheiban I,
• La Spina C,
• Cavallero E,
• Biondi-Zoccai G,
• Colombo F,
• Palmerini T,
• Marzocchi A,
• Tamburino C,
• Margheri M,
• Vecchi G,
• Sangiorgi G,
• Santarelli A,
• Bartorelli A,
• Briguori C,
• Vignali L,
• di Pede F,
• Ramondo A,
• Fantoni C,
• De Carlo M,
• Falsini G,
• Benassi A,
• Palmieri C,
• Filippone V,
• Sangiorgi D,
• De Servi S

EuroIntervention 2010;5:795-800

Published in Volume 5 Number 7, February 2010

Systematic reviews and meta-analyses "For Dummies"

• Biondi-Zoccai G,
• Abbate A,
• Sheiban I

EuroIntervention 2009;5:289-291

Published in Volume 5 Number 3, August 2009

Do we really need routine angiographic follow-up after percutaneous coronary drug-eluting stenting for unprotected left main disease?

• Giraudi E,
• Biondi-Zoccai G,
• Moretti C,
• Sciuto F,
• Omedè P,
• Sillano D,
• Garrone P,
• Iacovino C,
• Trevi GP,
• Sheiban I

Published in Volume 5 Supplement E, May 2009

Sex-related long-term differences after unprotected left main stenting: a multicenter Italian registry

• Cavallero E,
• La Spina C,
• Bollati M,
• Colombo F,
• Palmerini T,
• Tamburino C,
• Margheri M,
• Vecchi G,
• Sangiorgi G,
• De Servi S,
• Sheiban I

Published in Volume 5 Supplement E, May 2009

Impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients

• Bollati M,
• Biondi-Zoccai G,
• Palmerini T,
• Tamburino C,
• Margheri M,
• Vecchi G,
• Sangiorgi G,
• De Servi S,
• Sheiban I

Published in Volume 5 Supplement E, May 2009

Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of 718 patients. The failure in left main study (FAILS)

• Sillano D,
• Chieffo A,
• Colombo A,
• Vecchio S,
• Margheri M,
• Gunn J,
• Raina T,
• Liistro F,
• Bolognese L,
• Lee M,
• Tobis J,
• Iacovino C,
• Biondi-Zoccai G,
• Sheiban I

Published in Volume 5 Supplement E, May 2009

Treatment of chronic total occlusions: long-term safety and efficacy of drug-eluting versus bare-metal stents

• La Spina C,
• Moretti C,
• Sciuto F,
• Omedè P,
• Biondi-Zoccai G,
• Trevi GP,
• Sheiban I

Published in Volume 5 Supplement E, May 2009

Very long-term results comparing simple vs complex stenting strategy in the treatment of coronary bifurcation lesions

• Infantino V-A,
• Colombo F,
• Omedè P,
• Moretti C,
• Sciuto F,
• Biondi-Zoccai G,
• Trevi GP,
• Sheiban I

Published in Volume 5 Supplement E, May 2009

Elective implantation of sirolimus-eluting stents for bifurcated and non-bifurcated unprotected left main coronary artery lesions: clinical outcomes at one year

• Barragan P,
• Fajadet J,
• Sheiban I,
• Serruys PW,
• Colombo A,
• Seabra-Gomes R,
• Goy J-J,
• Cook S,
• Rubino P,
• Lefèvre T

EuroInterv.2008;4:262-270

Published in Volume 4 Number 2, August 2008

Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)

• Meliga E,
• García-García HM,
• Valgimigli M,
• Chieffo A,
• Biondi-Zoccai G,
• O’ Maree A,
• Gonzalo N,
• Cook S,
• Cruz-Gonzalez I,
• Marra S,
• De Servi S,
• Palacios I,
• Windecker S,
• van Domburg R,
• Colombo A,
• Sheiban I,
• Serruys PW

EuroInterv.2008;4:77-83

Published in Volume 4 Number 1, May 2008

Last nail in the coffin of late lumen loss?

• Biondi-Zoccai G,
• Agostoni P,
• Sheiban I

EuroInterv.2008;4:29-32

Published in Volume 4 Number 1, May 2008

Percutaneous coronary stenting in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis

• Biondi-Zoccai G,
• Moretti C,
• Abbate A,
• Lipinski M,
• De Luca G,
• Agostoni P,
• Meliga E,
• Goudreau E,
• Vetrovec G,
• Trevi GP,
• Sheiban I

EuroInterv.2007;3:409-415

Published in Volume 3 Number 3, November 2007

Making sense of the recent meta-analytical confusion concerning the safety of drug-eluting stents

• Biondi-Zoccai G,
• Agostoni P,
• Moretti C,
• Meliga E,
• Sheiban I

EuroInterv.2007;3:381-385

Published in Volume 3 Number 3, November 2007

Sirolimus-Eluting Stents vs Bare Metal Stents for the treatment of unprotected left main coronary artery stenosis

• Sheiban I,
• Meliga E,
• Moretti C,
• Fumagalli A,
• Omedè P,
• Sciuto F,
• Grossomarra W,
• Trevi GP

EuroInterv.2006;2:356-362

Published in Volume 2 Number 3, November 2006

One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease. Sirolimus stent vs. coronary artery bypass surgery and bare metal stent: insights from ARTS-II and ARTS-I

• Macaya C,
• García-García HM,
• Colombo A,
• Morice M-C,
• Legrand V,
• Kuck K-H,
• Sheiban I,
• Suttorp M,
• Carrié D,
• Vrolix M,
• Wittebols K,
• Stoll H-P,
• Donohoe D,
• Bressers M,
• Serruys PW

EuroInterv.2006;2:69-76

Published in Volume 2 Number 1, May 2006